Metabolic and Phenotypic Differences between Mice Producing a Werner Syndrome Helicase Mutant Protein and Wrn Null Mice.

Werner syndrome (WS) is a premature aging disorder caused by mutations in a RecQ-family DNA helicase, WRN. Mice lacking part of the helicase domain of the WRN orthologue exhibit many phenotypic features of WS, including metabolic abnormalities and a shorter mean life span. In contrast, mice lacking...

Full description

Bibliographic Details
Main Authors: Lucie Aumailley, Chantal Garand, Marie Julie Dubois, F Brad Johnson, André Marette, Michel Lebel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4598085?pdf=render
_version_ 1818131578147045376
author Lucie Aumailley
Chantal Garand
Marie Julie Dubois
F Brad Johnson
André Marette
Michel Lebel
author_facet Lucie Aumailley
Chantal Garand
Marie Julie Dubois
F Brad Johnson
André Marette
Michel Lebel
author_sort Lucie Aumailley
collection DOAJ
description Werner syndrome (WS) is a premature aging disorder caused by mutations in a RecQ-family DNA helicase, WRN. Mice lacking part of the helicase domain of the WRN orthologue exhibit many phenotypic features of WS, including metabolic abnormalities and a shorter mean life span. In contrast, mice lacking the entire Wrn protein (i.e. Wrn null mice) do not exhibit a premature aging phenotype. In this study, we used a targeted mass spectrometry-based metabolomic approach to identify serum metabolites that are differentially altered in young Wrn helicase mutant and Wrn null mice. An antibody-based quantification of 43 serum cytokines and markers of cardiovascular disease risk complemented this study. We found that Wrn helicase mutants exhibited elevated and decreased levels, respectively, of the anti-inflammatory cytokine IL-10 and the pro-inflammatory cytokine IL-18. Wrn helicase mutants also exhibited an increase in serum hydroxyproline and plasminogen activator inhibitor-1, markers of extracellular matrix remodeling of the vascular system and inflammation in aging. We also observed an abnormal increase in the ratio of very long chain to short chain lysophosphatidylcholines in the Wrn helicase mutants underlying a peroxisome perturbation in these mice. Remarkably, the Wrn mutant helicase protein was mislocalized to the endoplasmic reticulum and the peroxisomal fractions in liver tissues. Additional analyses with mouse embryonic fibroblasts indicated a severe defect of the autophagy flux in cells derived from Wrn helicase mutants compared to wild type and Wrn null animals. These results indicate that the deleterious effects of the helicase-deficient Wrn protein are mediated by the dysfunction of several cellular organelles.
first_indexed 2024-12-11T08:23:09Z
format Article
id doaj.art-5f299a8ac4cc475fa88a79176c94215b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T08:23:09Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5f299a8ac4cc475fa88a79176c94215b2022-12-22T01:14:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011010e014029210.1371/journal.pone.0140292Metabolic and Phenotypic Differences between Mice Producing a Werner Syndrome Helicase Mutant Protein and Wrn Null Mice.Lucie AumailleyChantal GarandMarie Julie DuboisF Brad JohnsonAndré MaretteMichel LebelWerner syndrome (WS) is a premature aging disorder caused by mutations in a RecQ-family DNA helicase, WRN. Mice lacking part of the helicase domain of the WRN orthologue exhibit many phenotypic features of WS, including metabolic abnormalities and a shorter mean life span. In contrast, mice lacking the entire Wrn protein (i.e. Wrn null mice) do not exhibit a premature aging phenotype. In this study, we used a targeted mass spectrometry-based metabolomic approach to identify serum metabolites that are differentially altered in young Wrn helicase mutant and Wrn null mice. An antibody-based quantification of 43 serum cytokines and markers of cardiovascular disease risk complemented this study. We found that Wrn helicase mutants exhibited elevated and decreased levels, respectively, of the anti-inflammatory cytokine IL-10 and the pro-inflammatory cytokine IL-18. Wrn helicase mutants also exhibited an increase in serum hydroxyproline and plasminogen activator inhibitor-1, markers of extracellular matrix remodeling of the vascular system and inflammation in aging. We also observed an abnormal increase in the ratio of very long chain to short chain lysophosphatidylcholines in the Wrn helicase mutants underlying a peroxisome perturbation in these mice. Remarkably, the Wrn mutant helicase protein was mislocalized to the endoplasmic reticulum and the peroxisomal fractions in liver tissues. Additional analyses with mouse embryonic fibroblasts indicated a severe defect of the autophagy flux in cells derived from Wrn helicase mutants compared to wild type and Wrn null animals. These results indicate that the deleterious effects of the helicase-deficient Wrn protein are mediated by the dysfunction of several cellular organelles.http://europepmc.org/articles/PMC4598085?pdf=render
spellingShingle Lucie Aumailley
Chantal Garand
Marie Julie Dubois
F Brad Johnson
André Marette
Michel Lebel
Metabolic and Phenotypic Differences between Mice Producing a Werner Syndrome Helicase Mutant Protein and Wrn Null Mice.
PLoS ONE
title Metabolic and Phenotypic Differences between Mice Producing a Werner Syndrome Helicase Mutant Protein and Wrn Null Mice.
title_full Metabolic and Phenotypic Differences between Mice Producing a Werner Syndrome Helicase Mutant Protein and Wrn Null Mice.
title_fullStr Metabolic and Phenotypic Differences between Mice Producing a Werner Syndrome Helicase Mutant Protein and Wrn Null Mice.
title_full_unstemmed Metabolic and Phenotypic Differences between Mice Producing a Werner Syndrome Helicase Mutant Protein and Wrn Null Mice.
title_short Metabolic and Phenotypic Differences between Mice Producing a Werner Syndrome Helicase Mutant Protein and Wrn Null Mice.
title_sort metabolic and phenotypic differences between mice producing a werner syndrome helicase mutant protein and wrn null mice
url http://europepmc.org/articles/PMC4598085?pdf=render
work_keys_str_mv AT lucieaumailley metabolicandphenotypicdifferencesbetweenmiceproducingawernersyndromehelicasemutantproteinandwrnnullmice
AT chantalgarand metabolicandphenotypicdifferencesbetweenmiceproducingawernersyndromehelicasemutantproteinandwrnnullmice
AT mariejuliedubois metabolicandphenotypicdifferencesbetweenmiceproducingawernersyndromehelicasemutantproteinandwrnnullmice
AT fbradjohnson metabolicandphenotypicdifferencesbetweenmiceproducingawernersyndromehelicasemutantproteinandwrnnullmice
AT andremarette metabolicandphenotypicdifferencesbetweenmiceproducingawernersyndromehelicasemutantproteinandwrnnullmice
AT michellebel metabolicandphenotypicdifferencesbetweenmiceproducingawernersyndromehelicasemutantproteinandwrnnullmice